Related Experiment Video
Updated: May 30, 2026

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
A tripartite complex composed of ETV6-NTRK3, IRS1 and IGF1R is required for ETV6-NTRK3-mediated membrane localization
C E Tognon1, M J Martin, A Moradian
1Department of Molecular Oncology, BC Cancer Research Centre, Vancouver, British Columbia, Canada.
Abstract:
ETV6-NTRK3 (EN), a chimeric tyrosine kinase generated by t(12;15) translocations, is a dominantly acting oncoprotein in diverse tumor types. We previously showed that insulin-like growth factor 1 receptor (IGF1R) is essential for EN-mediated oncogenesis and that insulin receptor substrate 1 (IRS1) is constitutively tyrosine phosphorylated and bound by EN in transformed cells. Given that IRS1 is also an adapter for IGF1R, we hypothesized that IRS1 might localize EN to IGF1R at the membrane to activate phosphatidylinositol 3-kinase (PI3K)-Akt, which is critical for EN oncogenesis. In this study, we examined EN/IRS1/IGF1R complexes in detail. We find that both IRS1 and kinase active IGF1R are required for EN transformation, that tyrosine phosphorylated IRS1 is present in high molecular weight complexes with EN and IGF1R, and that EN colocalizes with IGF1R at the plasma membrane. Both IGF1R kinase activity and an intact cytoplasmic Y950 residue, the IRS1-docking site of IGF1R, are required, confirming the importance of the IGF1R/IRS1 interaction for EN oncogenesis. The dual specificity IGF1R and insulin receptor (INSR) inhibitor, BMS-536924, blocks EN transformation activity, cell survival and its interaction with IRS proteins, and induces a striking shift of EN proteins to smaller sized molecular complexes. We conclude that a tripartite complex of EN, IRS1 and IGF1R localizes EN to the membrane and that this is essential for EN-mediated transformation. These findings provide an explanation for the observed IGF1R dependency of EN transformation. Blocking IGF1R kinase activity may, therefore, provide a tractable therapeutic strategy for the many tumor types driven by the EN oncoprotein.
Insights
The ETV6-NTRK3 (EN) oncoprotein requires insulin-like growth factor 1 receptor (IGF1R) and insulin receptor substrate 1 (IRS1) to localize to the cell membrane, driving cancer. Inhibiting IGF1R kinase activity may offer a new cancer therapy.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- ETV6-NTRK3 (EN) is a potent oncoprotein driving various cancers.
- Insulin-like growth factor 1 receptor (IGF1R) and insulin receptor substrate 1 (IRS1) are crucial for EN-mediated oncogenesis.
Purpose of the Study:
- To investigate the mechanism by which IRS1 facilitates EN localization to IGF1R at the plasma membrane.
- To elucidate the role of the EN/IRS1/IGF1R complex in activating phosphatidylinositol 3-kinase (PI3K)-Akt signaling for oncogenesis.
Main Methods:
- Analysis of EN/IRS1/IGF1R complexes in transformed cells.
- Assessment of EN transformation activity and cell survival using IGF1R/INSR inhibitor BMS-536924.
- Co-localization studies of EN and IGF1R at the plasma membrane.
Main Results:
- Both IRS1 and active IGF1R kinase are essential for EN-mediated cell transformation.
- Tyrosine-phosphorylated IRS1 forms high molecular weight complexes with EN and IGF1R.
- EN colocalizes with IGF1R at the plasma membrane, dependent on IGF1R kinase activity and Y950 residue.
- BMS-536924 inhibits EN transformation, cell survival, and IRS protein interaction, causing a shift in EN complex size.
Conclusions:
- A tripartite complex of EN, IRS1, and IGF1R is essential for localizing EN to the membrane and driving transformation.
- This interaction explains the dependence of EN-driven tumors on IGF1R.
- Targeting IGF1R kinase activity presents a potential therapeutic strategy for EN-driven cancers.
Related Concept Videos
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Protein Translocation Machinery on the ER Membrane
Sec61 protein conducting channel
In eukaryotes, the translocon complex comprises a core heterotrimeric translocator channel called the Sec61 complex. This channel includes three transmembrane proteins, Sec61α, Sec61β, and Sec61γ, and is the largest subunit of the translocon complex.
Intralumenal Vesicles and Multivesicular Bodies
TGF - β Signaling Pathway
Tail-anchoring of Proteins in the ER Membrane
